CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate of 5.10% as of 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation
us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate · last filed 2026-02-18
- 2025-12-27: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate 5.10%.
- 2024-12-28: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate 5.20%.
- 2023-12-30: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate 4.70%.
- 2022-12-31: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate 4.80%.
| Period end | Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate | Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate as first filed |
|---|---|---|
| 2025-12-27 | 5.10% 10-K · filed 2026-02-18 | |
| 2024-12-28 | 5.20% 10-K · filed 2026-02-18 | |
| 2023-12-30 | 4.70% 10-K · filed 2025-02-19 | |
| 2022-12-31 | 4.80% 10-K · filed 2024-02-14 | |
| 2021-12-25 | 1.80% 10-K · filed 2023-02-22 | |
| 2020-12-26 | 1.50% 10-K · filed 2022-02-16 | 1.48% 10-K · filed 2021-02-17 |
| 2019-12-28 | 2.14% 10-K · filed 2021-02-17 | |
| 2018-12-29 | 3.21% 10-K · filed 2020-02-11 | |
| 2017-12-30 | 2.82% 10-K · filed 2019-02-13 | |
| 2016-12-31 | 3.01% 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |